PSEG Centro de Pesquisa Clinica S.A.

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Amyloidosis3 trials
• ALS (motor neurone disease)1 trial
• Heart failure1 trial
• Migraine1 trial
• Myasthenia gravis1 trial
• Sarcoma1 trial

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Active, not recruiting4 trials
• Recruiting2 trials

Lead sponsor

• Intellia Therapeutics2 trials
• Ionis Pharmaceuticals, Inc.1 trial
• Ipsen1 trial
• Novo Nordisk A/S1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Active, not recruiting

  A Phase 3 Study of NTLA-2001 in ATTRv-PN

  NCT06672237· Phase 3· Intellia Therapeutics· Source

• Active, not recruiting

  A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

  NCT06625060· Phase 2· Ipsen· Source

• Recruiting

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  NCT06128629· Phase 3· Intellia Therapeutics· Source

  Contact: Trial Manager at Intellia

• Active, not recruiting

  A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

  NCT05070858· Phase 3· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)

  NCT04768972· Phase 3· Ionis Pharmaceuticals, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis2 recruiting
• Heart failure1 recruiting